CBA assists GlaxoSmithKline in the transfer of its R&D Centre, other properties and production sites to Aptuit
07-15-2021
The CBA team headed by Mattia Dalla Costa has assisted GlaxoSmithKline in the transfer of its R&D Centre, other properties and production sites to Aptuit, a pharmaceutical company in the German group Evotec, to which in 2010 the R&D Centre had been handed over under a loan for use agreement, in the context of a complex industrial reorganisation deal involving the two groups as well as several companies based in the USA, UK, Italy and Germany.
The international deal in question has involved several companies in the GSK group (Setfirst Limited, Glaxosmithkline Finance Plc, Glaxosmithkline Research & Development Limited, Glaxo Group Limited), assisted by CBA which had also assisted the GSK Group in 2010.
| Attachments | ||
|---|---|---|
| CBA with GSK | 240.33 KB |  |